GFAP and early-onset autosomal dominant Alzheimer disease: Interestingly, higher plasma GFAP levels were also found in Alzheimer’s disease patients and SIVD patients, presenting excellent accuracy (AUC 0.932) and moderate performance (AUC 0.786) in identifying those patients, respectively.